Samsung Biologics
Written on October 24, 2017 at , by admin
Financial Times recently reported that Samsung South Korea plans to launch generic version of a biological medicines by 2015 at half the price of the current Western prices. It claims that Samsung is gearing up to challenge the US and European pharmaceutical companies. It was stated that: The new production facility would be operated by […]